Page 26 - 2020-2021-Heroes-Program-Bklt-v1_fa_Neat

Daisy Richardson
Daisy Richardson, Executive Director Vaccines Analytical Research & Development, Merck & Co.,
Inc. Daisy’s contributions to Merck’s diverse pipeline include innovations in measurement science
spanning biologics and vaccines. Daisy earned her B.S. in Chemistry from Millsaps College and her
Ph.D. in Analytical Chemistry from the University of Cincinnati.

David Roush
David Roush is a Distinguished Scientist at Merck & Co., Inc. at Kenilworth, NJ, USA. David has a
B.S. in Chemical Engineering from Rice University and holds a Ph.D. in Chemical Engineering from
the University of Houston, USA.

Patricia Rowicki
Patricia has over 15 years of experience in protein purification development. She received training
in Biochemistry from Richard Stockton University and pursued a M.S. in Regulatory Affairs from
Northeastern University. She is currently an Associate Principal Scientist in the Downstream Process
Development and Engineering group at Merck.

Mohammed Shameem
Mohammed Shameem is the Vice President and Head of Drug Product and New Technology
Development at Regeneron Pharmaceuticals, USA. He is a Pharmacist by training and received his
Ph.D. in Pharmaceutical Sciences, Kumamoto University, Japan. His recent noteworthy accomplishments
include Regeneron’s COVID-19 monoclonal antibody cocktail product development for SARS-CoV-2.

26 #HeroesofChemistry